MaxCyte, Inc. Common Stock

MXCTNASDAQ • USD
1.18 USD
↘ 0.01 (0.84%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

MaxCyte, Inc. Common Stock (MXCT) is currently trading at $1.18. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Notable factors include negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place MXCT at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.18
High?$1.18
Low?$1.18
Prev. Close?$1.19
Volume?0
Avg. Volume?1.6M
Bid / Ask
Bid?$1.00 × 100
Ask?$1.35 × 100
Spread?$0.35
Midpoint?$1.18
Valuation & Ratios
Market Cap?122.9M
Shares Out?103.3M
Float?93.5M
Float %?90.6%
P/E Ratio?N/A
P/B Ratio?0.81
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Employees
91
Market Cap
122.9M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2019-12-05
Address
9713 KEY WEST AVENUE,
ROCKVILLE, MD 20850
Phone: 301-517-5556
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
28
Momentum?
88
Short Sent.?
95
Piotroski F-Score?5/9Mixed
Altman Z-Score?1.76Grey
Confidence?51%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.69%Low
Short Interest?1.6M
Days to Cover?1.3
Free Float93.5M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?7.83Strong
Quick Ratio?7.37Strong
Cash Ratio?0.84Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.81CHEAP▾
P/S?
Peers
100
S&P
43
3.57FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.8CHEAP▾
EV/Sales?
Peers
100
S&P
58
3.19FAIR▾
Returns & Efficiency
ROE?
S&P
8
-18.5%WEAK▾
ROA?
S&P
3
-15.3%WEAK▾
Cash Flow & Enterprise
FCF?$-21449000
Enterprise Value?$109.5M
Fundamentals ratios updated end of day